Business Context and Reporting Period
This Form 6-K filing by Guardforce AI Co., Limited covers the month of December 2025, with a report date of December 19, 2025. The filing details the adoption of a Rights Agreement by the Board of Directors on December 15, 2025, designed to protect shareholders from coercive or unfair takeover tactics.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and capital structure changes related to the Rights Plan.
- Record Date: December 15, 2025
- Right Grant: One Right per outstanding Ordinary Share
- Exercise Price: $8.44 per Preferred Share (subject to adjustment)
- Redemption Price: $0.12 per Right
- Expiration Date: December 15, 2035
Material Changes
The primary material change is the implementation of a poison pill (Rights Plan) effective as of the Record Date. Key structural changes include:
- Trigger Threshold: The plan activates if any person or group acquires 10% or more of the voting power without Board approval.
- Founder Exemption: An initial 25% exempted percentage is granted to the Company's founders.
- Flip-In Feature: Upon triggering, Rights holders (excluding the Acquiring Person) may purchase Ordinary Shares with a market value equal to two times the purchase price.
- Flip-Over Feature: In the event of a merger or asset sale following a trigger, Rights may be exchanged for shares of the acquiring company with a market value equal to two times the purchase price.
Guidance, Outlook, and Risks
Management Commentary: The Board adopted the Rights Agreement to enable shareholders to realize long-term investment value and prevent coercive takeover tactics. The Board retains the right to redeem the Rights in whole at $0.12 per Right prior to the trigger event.
Risks and Contingencies:
- Dilution Risk: Significant dilution is imposed on any Acquiring Person exceeding the 10% threshold.
- Amendment Restrictions: After the Distribution Date, amendments cannot be made without holder consent if they adversely affect Rights holders.
- Anti-Dilution Adjustments: Purchase prices and share counts adjust for stock splits, dividends, or reclassifications, though adjustments are not required unless cumulative changes alter the price by at least 1%.
Investor Verification Checklist
- Verify the exact number of outstanding Ordinary Shares as of the December 15, 2025 Record Date to calculate total Rights issued.
- Confirm the current market price of Ordinary Shares to assess the economic impact of the "two times purchase price" flip-in feature.
- Review the full text of the Rights Agreement (Exhibit 4.1) for specific definitions of "Acquiring Person" and related exemptions.
- Monitor for any Board announcements regarding the redemption of Rights prior to the trigger event.
- Check for subsequent filings regarding the separation of Rights certificates if a potential acquirer approaches the 10% threshold.